Home Other Building Blocks 223488-57-1
223488-57-1,MFCD09833940
Catalog No.:AA00BF4O

223488-57-1 | Evatanepag

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$92.00   $64.00
- +
5mg
98%
in stock  
$201.00   $141.00
- +
10mg
98%
in stock  
$318.00   $223.00
- +
25mg
98%
in stock  
$669.00   $468.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BF4O
Chemical Name:
Evatanepag
CAS Number:
223488-57-1
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.5652
MDL Number:
MFCD09833940
SMILES:
OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)C(C)(C)C
Properties
Computed Properties
 
Complexity:
722  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
10  
XLogP3:
4.2  

Downstream Synthesis Route

[1]Patent:US2005/65133,2005,A1.Locationinpatent:Page/Pagecolumn45

[2]Patent:US6498172,2002,B1

[1]Patent:US2005/65133,2005,A1.Locationinpatent:Page/Pagecolumn45

223488-57-1   
(3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-aceticacidsodiumsalthemihydrate 

[1]Patent:WO2009/27811,2009,A2.Locationinpatent:Page/Pagecolumn15;29-30

[2]Patent:WO2009/27811,2009,A2.Locationinpatent:Page/Pagecolumn15

[1]Patent:WO2009/27811,2009,A2.Locationinpatent:Page/Pagecolumn30-31

Literature

Title: Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.

Journal: Bioorganic & medicinal chemistry letters 20090401

Title: CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20081001

Title: In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.

Journal: Life sciences 20080116

Title: Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.

Journal: Prostaglandins, leukotrienes, and essential fatty acids 20080101

Title: Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20050801

Title: Prostaglandin E2 receptor subtype EP-2 is not involved in the induction of non-pregnant guinea pig uterine contractions associated with terminal pregnancy.

Journal: Prostaglandins, leukotrienes, and essential fatty acids 20041201

Title: A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031101

Title: An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20030527

Title: Cameron KO, et al. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. Bioorg Med Chem Lett. 2009 Apr 1;19(7):2075-8.

Title: Judith Plaza, et al. In Vitro and In Vivo Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity. Allergy Asthma Immunol Res. 2020 Jul;12(4):712-728.

Title: V M Paralkar, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6736-40.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 223488-57-1
Tags:223488-57-1 Molecular Formula|223488-57-1 MDL|223488-57-1 SMILES|223488-57-1 Evatanepag